USANA HEALTH SCIENCES INC
For the period ended Feb 17, 2026. Filed Feb 18, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Feb 17, 2026 · Filed Feb 18, 2026
USNA$13.63-1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Quarter Ended | Year Ended | |||
|---|---|---|---|---|
| January 3, 2026 | December 28, 2024 | January 3, 2026 | December 28, 2024 | |
| Net (loss) earnings attributable to USANA (GAAP) | $(1,775) | $4,454 | $10,760 | $42,030 |
| (Loss) earnings per common share - Diluted (GAAP) | $(0.10) | $0.23 | $0.58 | $2.19 |
| Weighted Average common shares outstanding - Diluted | 18,302 | 19,104 | 18,574 | 19,162 |
| Adjustment to net (loss) earnings: | ||||
| Transaction, integration and transition costs - Hiya | $443 | $8,243 | $1,314 | $8,243 |
| Inventory step-up - Hiya | — | 38 | 1,126 | 38 |
| Cost realignment | 6,463 | — | 6,463 | — |
| Impairment | 6,967 | — | 6,967 | — |
| Gain on disposal of assets | (3,240) | — | (3,240) | — |
| Amortization of intangible assets - Hiya | 4,798 | 294 | 18,164 | 294 |
| Adjustments to net (loss) earnings attributable to noncontrolling interest | (1,015) | (70) | (4,081) | (70) |
| Income tax effect of adjustments to net earnings (loss) | (1,658) | (823) | (1,662) | (823) |
| Adjusted net earnings attributable to USANA | $10,983 | $12,136 | $35,811 | $49,712 |
| Adjusted earnings per common share - Diluted | $0.60 | $0.64 | $1.93 | $2.59 |
| Weighted average common shares outstanding - Diluted | 18,302 | 19,104 | 18,574 | 19,162 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.